Table 2 Procedural data and 30 days results, before and after matching ORE versus ICE.

From: Enhanced recovery after minimally invasive valve surgery – ultra-fast extubation versus standard weaning strategy

Procedural data and 30-day results

Before matching

After matching

ORE (n = 387)

ICE (n = 227)

p-value

ORE (n = 122)

ICE (n = 122)

p-value

Cross Clamp time, minutes

81.97 (78.9–85.0)

133.3 (124.9-141.7)

< 0.01

94.23 (88.1–100.0)

94.84 (88.4-101.2)

0.92

Mitral valve procedure, n (%)

240 (62.0)

175 (77.1)

< 0.01

88 (72.1)

75 (61.5)

0.10

Aortic valve procedure, n (%)

117 (30.2)

44 (19.4)

0.03

28 (22.9)

40 (32.8)

0.11

Tricuspid valve procedure, n (%)

7 (1.8)

3 (1.3)

0.75

2 (1.6)

0 (0)

0.49

Mitral and aortic valve, n (%)

9 (2.3)

1 (0.4)

0.10

2 (1.6)

2 (1.6)

1.00

Mitral and tricuspid valve, n (%)

14 (3.6)

5 (2.2)

0.47

2 (1.6)

5 (4.1)

1.00

pRBC, n (%)

1.53 (1.2–1.8)

3.36 (1.9–4.8)

0.14

1.37 (0.98–1.8)

3.54 (1.1–5.9)

< 0.01

FFPs, n (%)

0.61 (0.4–0.8)

1.52 (1.1-2.0)

< 0.01

0.51 (0.2–0.8)

1.33 (0.8–1.9)

< 0.01

Conversion to sternotomy, n (%)

2 (0.51)

5 (2.2)

0.06

1 (0.8)

1 (0.8)

1.00

ASD repair, n (%)

31 (8.0)

24 (10.6)

0.29

9 (7.4)

11 (9.0)

0.61

Delirium, n (%)

29 (7.5)

30 (13.2)

0.02

11 (9.0)

16 (13.1)

0.40

30-day mortality, n (%)

1 (0.3)

8 (3.5)

< 0.01

0 (0)

5 (4.0)

0.02

TIA, n (%)

1 (0.3)

1 (0.4)

0.70

1 (0.8)

1 (0.8)

0.99

Stroke, n (%)

5 (1.3)

4 (1.8)

0.64

3 (2.5)

4 (3.3)

0.68

All cause in hospital mortality, n (%)

2 (0.5)

14 (6.1)

< 0.01

0 (0)

6 (4.9)

0.04

Aphasia, n (%)

2 (0.5)

2 (0.8)

0.59

2 (1.6)

2 (1.6)

1.00

Aspiration, n (%)

3 (0.7)

2 (0.8)

0.89

1 (0.8)

0 (0)

0.32

Atrial fibrillation, n (%)

105 (27.1)

68 (29.9)

0.58

38 (31.1)

35 (28.7)

0.74

Pericardial effusion, n (%)

28 (7.2)

12 (5.3)

0.36

5 (4.0)

9 (7.4)

0.45

Cardiogenic shock, n (%)

6 (1.5)

2 (0.6)

0.48

1 (0.8)

2 (1.6)

0.55

ECMO, n (%)

1 (0.2)

15 (6.6)

0.75

1 (0.8)

6 (4.9)

0.11

GI bleeding, n (%)

1 (0.3)

3 (1.3)

0.11

0 (0)

2 (1.6)

0.49

GI ischemia, n (%)

0 (0)

4 (1.7)

< 0.01

0 (0)

3 (2.5)

0.08

Hemiplegia, n (%)

2 (0.5)

7( 3.1)

0.75

1 (0.8)

5 (4.0)

0.23

Inotropic support for 24 h

57 (14.7)

53 (23.3)

0.01

20 (16.4)

29 (23.8)

0.13

LCOS, n (%)

5 (1.3)

15 (6.6)

< 0.01

1 (0.8)

8 (6.6)

0.03

Left ventricular decompensation, n (%)

37 (9.5)

29 (12.8)

0.20

14 (11.5)

11 (9.0)

0.78

Multi-organ failure, n (%)

2 (0.5)

6 (2.6)

0.02

0 (0)

4 (3.3)

0.12

Need for pacemaker, n (%)

16 (4.1)

10 (4.4)

0.87

5 (4.0)

8 (6.6)

0.37

Pneumonia, n (%)

14 (3.6)

22 (9.7)

0.005

5 (4.0)

8 (6.6)

0.37

Prolonged ICU stay (≥ 3d), n (%)

56 (14.5)

71 (31.3)

< 0.01

12 (9.8)

37 (30.3)

< 0.01

Prolonged ventilation (≥ 24 h), n (%)

2 (0.5)

46 (20.3)

< 0.01

0 (0)

23 (18.9)

< 0.01

Repeated intubation, n (%)

23 (5.9)

26 (11.5)

0.02

7 (5.7)

12 (9.8)

0.27

Respiratory insufficiency, n (%)

39 (10.0)

59 (26.0)

< 0.01

13 (10.7)

29 (23.8)

0.01

Tamponade and re-exploration, n (%)

8 (2.0)

5 (2.2)

0.91

0 (0)

4 (3.3)

0.12

Superficial wound infection, n (%)

7 (1.8)

11 (4.8)

0.03

0 (0)

4 (3.3)

0.12

Renal failure, n (%)

13 (3.3)

23 (18.9)

< 0.01

3 (2.5)

12 (9.8)

0.01

Renal failure requiring dialysis, n (%)

5 (1.2)

14 (6.1)

< 0.01

3 (2.5)

7 (5.7)

0.19

ICU stay, days

2.71 (2.1–3.2)

6.82 (3.9–9.7)

< 0.01

2.54 (1.8–3.3)

7.1 (2.0-12.2)

0.07

Hospital stay, days

12.01 (11.1–12.9)

17.43 (13.8–21.0)

< 0.01

11.9 (10.7–13.3)

16.9 (10.8–23.2)

0.11

Coma, n (%)

1 (0.3)

2 (0.8)

0.56

0 (0)

1 (0.8)

0.31

Chronic renal failure, n (%)

21 (9.2)

16 (7.0)

0.03

3 (2.5)

6 (4.9)

0.45

Death, n (%)

1 (0.3)

8 (3.5)

< 0.01

0 (0)

7 (5.7)

0.02

  1. Significant values are in bold.